ChemPartner(SZ:300149) Zheng Quan Shi Bao Wang·2025-09-01 10:53Core Insights - The strategic cooperation between Ruizhi Pharmaceutical and Haiyou Biological was officially established on August 29, focusing on the development of small nucleic acid drugs and innovative delivery technologies [1] Company Summary - Ruizhi Pharmaceutical (300149) and Haiyou Biological will leverage their strengths in small nucleic acid drug research and innovative delivery technology [1] - The collaboration aims to enhance the development and upgrade of new delivery systems, specifically targeting extrahepatic delivery [1] Industry Summary - The partnership is positioned at the forefront of the industry, aiming to expand the application boundaries of small nucleic acid drugs [1] - The initiative is expected to bring more possibilities for the treatment of extrahepatic tissue diseases [1]